tiprankstipranks
Trending News
More News >
Bliss Gvs Pharma Limited (IN:BLISSGVS)
:BLISSGVS
India Market

Bliss Gvs Pharma Limited (BLISSGVS) Financial Statements

Compare
2 Followers

Bliss Gvs Pharma Limited Financial Overview

Bliss Gvs Pharma Limited's market cap is currently ₹18.71B. The company's EPS TTM is ₹; its P/E ratio is 17.02; and it has a dividend yield of 0.28%. Bliss Gvs Pharma Limited is scheduled to report earnings on January 27, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 8.10B₹ 7.66B₹ 7.47B₹ 7.38B₹ 5.69B
Gross Profit₹ 3.96B₹ 2.49B₹ 3.50B₹ 3.47B₹ 2.40B
Operating Income₹ 2.84B₹ 1.23B₹ 1.01B₹ 950.22M₹ 830.25M
EBITDA₹ 1.27B₹ 1.49B₹ 1.35B₹ 762.37M₹ 1.27B
Net Income₹ 842.99M₹ 754.54M₹ 708.59M₹ 150.40M₹ 684.91M
Balance Sheet
Cash & Short-Term Investments₹ 1.41B₹ 1.41B₹ 684.11M₹ 1.35B₹ 616.64M
Total Assets₹ 13.01B₹ 12.14B₹ 11.57B₹ 11.09B₹ 10.77B
Total Debt₹ 881.04M₹ 998.40M₹ 1.02B₹ 1.09B₹ 1.22B
Net Debt₹ -1.25B₹ 767.00M₹ 769.43M₹ 874.76M₹ 1.09B
Total Liabilities₹ 2.09B₹ 2.11B₹ 2.39B₹ 2.62B₹ 2.49B
Stockholders' Equity₹ 10.50B₹ 9.67B₹ 8.84B₹ 8.19B₹ 8.08B
Cash Flow
Free Cash Flow₹ 298.48M₹ 1.24B₹ -594.86M₹ 614.77M₹ 548.45M
Operating Cash Flow₹ 1.06B₹ 1.52B₹ 343.13M₹ 1.35B₹ 639.69M
Investing Cash Flow₹ -754.41M₹ -1.33B₹ -77.51M₹ -929.75M₹ -469.91M
Financing Cash Flow₹ -303.45M₹ -208.93M₹ -249.38M₹ -237.30M₹ -207.98M
Currency in INR

Bliss Gvs Pharma Limited Earnings and Revenue History

Bliss Gvs Pharma Limited Debt to Assets

Bliss Gvs Pharma Limited Cash Flow

Bliss Gvs Pharma Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.